J&J dumps $915M de­vel­op­ment deal with Han­mi as an­oth­er Big Phar­ma aban­dons dis­as­ter-prone Ko­re­an drug­mak­er

An­oth­er one of Han­mi’s Big Phar­ma R&D al­liances has end­ed up on the rocks.

To­day it’s J&J’s turn to walk away from the South Ko­re­an phar­ma com­pa­ny, writ­ing off a $105 mil­lion up­front and every­thing else it has spent try­ing to ad­vance a new drug for di­a­betes and obe­si­ty since ink­ing the deal close to 4 years ago.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER